Evidence map›Paper›PMID 41211037›Full record

ArticleThe Pan African medical journal2025

Insights from a measles outbreak root cause analysis in Ethiopia - 2024.

Mikias Alayu Alemu, Sisay Temesgen Dema, Habtamu Alemay Anteneh, Habtamu Tilahun Guade, Abay Hagos Gebrekidan, Amare Mengistu Mersha, Gebre Asmamaw Lakew, Yonas Asefa Tufa, Endale Zemene Shibeshi, Gizaw Teka Nibzane and 14 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Mikias Alayu AlemuEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Sisay Temesgen DemaEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Habtamu Alemay AntenehWorld Health Organization, Country Office for Ethiopia, Addis Ababa, Ethiopia.
Habtamu Tilahun GuadeEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Abay Hagos GebrekidanWorld Health Organization, Country Office for Ethiopia, Addis Ababa, Ethiopia.
Amare Mengistu MershaWorld Health Organization, Country Office for Ethiopia, Addis Ababa, Ethiopia.
Gebre Asmamaw LakewWorld Health Organization, Country Office for Ethiopia, Addis Ababa, Ethiopia.
Yonas Asefa TufaEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Endale Zemene ShibeshiAfrican Field Epidemiology Network (AFENET), Addis Ababa, Ethiopia.
Gizaw Teka NibzaneEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Fasil Teshager HailemariamWorld Health Organization, Country Office for Ethiopia, Addis Ababa, Ethiopia.
Yamlak Gindola KitaEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Fentaw YimamEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Wondimu Bekele AyanaWorld Health Organization, Country Office for Ethiopia, Addis Ababa, Ethiopia.
Tirhas HailekirosEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Kefyalew AmeneEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Rahel AtakiltiEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Emebet AlemuOromia Regional Health Bureau, Addis Ababa, Ethiopia.
Ommer YeshawAmhara Regional Health Bureau, Bahir Dar, Ethiopia.
Sarai MalumoWorld Health Organization, Country Office for Ethiopia, Addis Ababa, Ethiopia.
Melkamu Ayalew KokebeMinistry of Health-Ethiopia, Addis Ababa, Ethiopia.
Mesfin Wossen GetanehEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Melkamu Abte AfeleEthiopian Public Health Institute (EPHI), Addis Ababa, Ethiopia.
Balcha Girma MasreshaVaccine-preventable Diseases Program, World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Introduction: Ethiopia has been implementing measles elimination strategies since 2003, including periodic supplemental immunisation activities every 2-3 years, and the introduction of a second dose measles vaccine in 2018. At national level, the coverage for first and second dose measles vaccine is 61% and 53% respectively. In the past decade, populations displacements and service disruptions due to natural and man-made disasters, exacerbated by the impact of the COVID-19 pandemic on the sub-optimally functioning immunisation system, have contributed to multiple measles outbreaks in the country. Methods: between July and August of 2024, a total of 44 woredas conducted a measles outbreak response vaccination campaign. Among these, 11 woredas were selected purposively to implement an outbreak root cause analysis exercise. Analysis of data and document reviews were done at woreda and health facility levels, along with interview of immunization program officers at different administrative levels, and interviews of care givers of confirmed measles cases. Results: in 2024, a total of 4664 confirmed measles cases and 24 deaths were reported to the national level from the 11 woredas. Despite reported high administrative vaccine coverage at the woreda level, only 56% of the measles cases had received at least one dose of measles vaccine, as seen during household visits. More than half (55%) of the 11 woredas do not have any facility that offers daily vaccination services, due to staff shortage (36%), concerns of vaccine wastage (36%), and lack of operational funding (18%). Twelve (44%) out of the 27 health posts and one-third (8 of 24) of the health centers do not give measles vaccines in every vaccination session. Cancellations of vaccination sessions were reported from 24 health centers and 27 health posts in 4 woredas due to various reasons including staff shortage, vaccine stockout, lack of means of transportation for field trips and electric power interruption. Non vaccination due to a combination of these multiple factors was identified as the root cause of the measles outbreaks. Conclusion: there are cross-cutting systemic factors that contributed to the measles outbreaks in various woredas, alongside contextual factors which differ from one health facility to another and between woredas. It is important that these findings are used to develop tailored efforts to strengthen routine immunisation services within the service catchment areas. Root cause analysis should be implemented as part of every outbreak investigation and response efforts.

Indexed as

Disease OutbreaksImmunization ProgramsMeaslesMeasles VaccineVaccinationVaccination CoverageCOVID-19EthiopiaHumansRoot Cause AnalysisMeasles VaccineEthiopiaMeaslesoutbreakroot cause analysisvaccination

Identifiers

PMID41211037
PMCPMC12595561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.